ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 23 Dec 2019
Last Applicant/ Owned by
Connaught House
Dublin 4
IE
Serial Number
86817594 filed on 12th Nov 2015
Registration Number
N/A
Correspondent Address
Norm J. Rich
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LONSARIS
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervou Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
Mark Details
Serial Number
No 86817594
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 029318-2659
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Dec 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 23rd Dec 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| 09th May 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th May 2019 | EXTENSION 5 GRANTED |
| 08th May 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th May 2019 | EXTENSION 5 FILED |
| 02th May 2019 | TEAS EXTENSION RECEIVED |
| 04th Sep 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 31st Aug 2018 | EXTENSION 4 GRANTED |
| 31st Aug 2018 | EXTENSION 4 FILED |